BackgroundPancreatoduodenectomy (PD) is a complex abdominal surgery, and the adoption of robotic PD has been on the rise because of its numerous benefits. This study aimed to investigate the current PD trends, focusing on advancements in robotic surgery.MethodsBetween 2015 and 2023, 1231 patients underwent open PD, whereas 630 underwent robot‐assisted PD (RAPD). Demographics and surgical outcomes were analyzed according to the time period. Moreover, a propensity score‐matched (PSM) analysis was performed to evaluate the clinical outcomes.ResultsThe proportion of RAPD cases gradually increased from 6.3% in 2015 to 50.9% in 2020, reaching a plateau of >50% thereafter. The proportion of patients receiving neoadjuvant chemotherapy increased during the late period (11.4% vs. 17.6%), with many of these patients undergoing open PD. Additionally, RAPD was performed in patients with a high probability of postoperative pancreatic fistula. However, the two groups demonstrated no significant difference in the occurrence of clinically relevant postoperative pancreatic fistula (10.6% vs. 9.5%, p = .532). Among periampullary cancer cases, RAPD demonstrated comparable survival outcomes to open PD after PSM (5‐year survival rate: 61.8% vs. 49.8%, p = .189).ConclusionsRAPD has become a stable approach, accounting for over 50% of all PD cases in high‐volume centers, and it can be safely performed. However, open PD remains important owing to the development of neoadjuvant therapy and the aging population. Therefore, establishing appropriate indications to maximize the benefits of both RAPD and open PD is necessary.